SECTION 310:638-5-9. Quality assurance and quality control

(a)   Quality assurance. Drug screen testing facilities shall have a quality assurance program which encompasses all aspects of the testing process including but not limited to specimen acquisition, chain of custody, security and reporting of results, initial and confirmatory testing, and validation of analytical procedures. Quality assurance procedures shall be designed, implemented, and reviewed to monitor the conduct of each step of the process of testing for drugs.

(b)   Quality control.

(1)   Each analytical run of specimens to be screened shall include:

(A)   Urine, hair, or saliva specimens certified to contain no drug;

(B)   Urine, hair, or saliva positive controls with the drug or metabolite at or near the threshold (cutoff).

(2)   Implementation of procedures to ensure that carryover does not contaminate the testing of an individual's specimen shall be documented.

[Source: Added at 11 Ok Reg 4339, eff 7-14-94 (emergency); Added at 12 Ok Reg 517, eff 12-12-94 (emergency); Added at 12 Ok Reg 3069, eff 7-27-95; Amended at 17 Ok Reg 381, eff 11-1-99 (emergency); Amended at 17 Ok Reg 2045, eff 6-12-00; Amended at 24 Ok Reg 1183, eff 4-2-07 (emergency); Amended at 25 Ok Reg 2436, eff 7-11-08]